title: Rituximab in the treatment of shrinking lung syndrome in systemic lupus erythematosus.
abstract: Shrinking lung syndrome (SLS) is a rare manifestation of systemic lupus erythematosus. We report the case of a patient with non-responding SLS (neither to glucocorticoids nor immunosupresors), who showed remarkable improvement after the onset of treatment with rituximab. Although there is a little evidence, treatment with rituximab could be proposed in SLS when classical treatment fails.
authors: Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Barcelona, España. Electronic address: ppenacoba@santpau.cat.
authors: Patricia
authors: P
authors: Peñacoba Toribio
authors: Unidad de Reumatología, Servicio de Medicina Interna, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
authors: María Emilia
authors: ME
authors: Córica Albani
authors: Unidad de Trastornos Respiratorios del Sueño, Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Centro de Investigación Biomédica en Red en Enfermedades Respiratorias (CibeRes), Universidad Autónoma de Barcelona, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
authors: Mercedes
authors: M
authors: Mayos Pérez
authors: Unidad de Reumatología, Servicio de Medicina Interna, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
authors: Arturo
authors: A
authors: Rodríguez de la Serna
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D004417:Dyspnea / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000209:etiology*; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008875:Middle Aged; D000069283:Rituximab / Q000627:therapeutic use*; D013577:Syndrome
chemical_list: D018501:Antirheumatic Agents; D000069283:Rituximab
keywords: Glucocorticoides; Glucocorticoids; Lupus eritematoso sistémico; Rituximab; Shrinking lung syndrome; Systemic lupus erythematosus; Síndrome del pulmón encogido